melatonin has been researched along with Canine Diseases in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of the study was to evaluate intermediate adrenal steroid hormones (ISH) in neutered dogs with hair cycle arrest (Alopecia X) during treatment with melatonin, and to see if hair re-growth is associated with sex hormone concentrations within the normal ranges." | 9.11 | Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane. ( Frank, LA; Hnilica, KA; Oliver, JW, 2004) |
| "Melatonin is a hormone produced and secreted primarily by the pineal gland and mainly metabolised in the liver." | 5.56 | Serum melatonin in dogs with congenital portosystemic shunting, with and without hepatic encephalopathy. ( Ferreira, MDF; Gow, AG; Mellanby, RJ, 2020) |
| " We assessed the effect of melatonin on postoperative complications of canine cataract surgery." | 5.22 | Preliminary findings on the effect of melatonin on the clinical outcome of cataract surgery in dogs. ( Álvarez, J; Calcagno, J; Rosenstein, RE; Sande, PH, 2016) |
| "The purpose of the study was to evaluate intermediate adrenal steroid hormones (ISH) in neutered dogs with hair cycle arrest (Alopecia X) during treatment with melatonin, and to see if hair re-growth is associated with sex hormone concentrations within the normal ranges." | 5.11 | Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane. ( Frank, LA; Hnilica, KA; Oliver, JW, 2004) |
| "Melatonin is a hormone produced and secreted primarily by the pineal gland and mainly metabolised in the liver." | 1.56 | Serum melatonin in dogs with congenital portosystemic shunting, with and without hepatic encephalopathy. ( Ferreira, MDF; Gow, AG; Mellanby, RJ, 2020) |
| "Melatonin has shown antitumor effects on cancer mammary cells; nevertheless, its effects have been poorly evaluated on canine mammary cancer stem-like cells." | 1.51 | Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells. ( Arias, JI; Guzmán, S; Serrano, C; Torres, CG, 2019) |
| "Melatonin has oncostatic actions and IL-25 is active in inflammatory processes that induce apoptosis in tumor cells AIM: The aim of this study was to evaluate melatonin and IL-25 in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumor cells cultured as monolayers and tridimensional structures." | 1.46 | Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells. ( Borin, TF; Gelaleti, GB; Hellmén, E; Maschio-Signorini, LB; Moschetta, MG; Viloria-Petit, AM; Zuccari, DAPC, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Pongkan, W | 1 |
| Piamsiri, C | 1 |
| Dechvongya, S | 1 |
| Punyapornwitthaya, V | 1 |
| Boonyapakorn, C | 1 |
| Verschuuren, MUMY | 1 |
| Schlotter, YM | 1 |
| van Geijlswijk, IM | 1 |
| van der Lugt, JJ | 1 |
| Gehring, R | 1 |
| Sacchettino, L | 1 |
| Gatta, C | 1 |
| Maruccio, L | 1 |
| Boncompagni, C | 1 |
| Napolitano, F | 1 |
| Avallone, L | 1 |
| d'Angelo, D | 1 |
| Oh, A | 1 |
| Foster, ML | 1 |
| Lunn, KF | 1 |
| Mowat, FM | 1 |
| Serrano, C | 1 |
| Guzmán, S | 1 |
| Arias, JI | 1 |
| Torres, CG | 1 |
| Ferreira, MDF | 1 |
| Mellanby, RJ | 1 |
| Gow, AG | 1 |
| Gelaleti, GB | 2 |
| Borin, TF | 1 |
| Maschio-Signorini, LB | 1 |
| Moschetta, MG | 2 |
| Hellmén, E | 1 |
| Viloria-Petit, AM | 1 |
| Zuccari, DAPC | 1 |
| Lopes, JR | 1 |
| Maschio, LB | 1 |
| Jardim-Perassi, BV | 1 |
| Ferreira, LC | 1 |
| Martins, GR | 1 |
| De Campos Zuccari, DA | 1 |
| Sande, PH | 1 |
| Álvarez, J | 1 |
| Calcagno, J | 1 |
| Rosenstein, RE | 1 |
| Perego, R | 1 |
| Proverbio, D | 1 |
| Roccabianca, P | 1 |
| Spada, E | 1 |
| RICKARDS, DA | 1 |
| Frank, LA | 2 |
| Hnilica, KA | 1 |
| Oliver, JW | 1 |
| Diaz, SF | 1 |
| Torres, SM | 1 |
| Nogueira, SA | 1 |
| Gilbert, S | 1 |
| Jessen, CR | 1 |
| Donnell, RL | 1 |
| Kania, SA | 1 |
| Kirk, RW | 1 |
3 trials available for melatonin and Canine Diseases
| Article | Year |
|---|---|
The efficacy of subcutaneous slow-release melatonin implants in the prevention of canine flank alopecia recurrence is uncertain: A double-blind, randomized, placebo-controlled study.
Topics: Alopecia; Animals; Dog Diseases; Dogs; Double-Blind Method; Melatonin; Skin | 2022 |
Preliminary findings on the effect of melatonin on the clinical outcome of cataract surgery in dogs.
Topics: Animals; Antioxidants; Cataract Extraction; Dog Diseases; Dogs; Female; Male; Melatonin; Postoperati | 2016 |
Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alopecia; Androstenedion | 2004 |
12 other studies available for melatonin and Canine Diseases
| Article | Year |
|---|---|
Short-term melatonin supplementation decreases oxidative stress but does not affect left ventricular structure and function in myxomatous mitral valve degenerative dogs.
Topics: Animals; Dietary Supplements; Dog Diseases; Dogs; Melatonin; Mitral Valve; Mitral Valve Insufficienc | 2022 |
Combining cannabis and melatonin treatment with a rehabilitation program improved symptoms in a dog with compulsive disorder: A case report.
Topics: Animals; Cannabis; Compulsive Behavior; Dog Diseases; Dogs; Male; Melatonin | 2023 |
Circulating neurohormone imbalances in canine sudden acquired retinal degeneration syndrome and canine pituitary-dependent hypercortisolism.
Topics: Animals; Case-Control Studies; Dog Diseases; Dogs; Dopamine; Melatonin; Pituitary ACTH Hypersecretio | 2019 |
Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Survival; Dog Diseases; Dogs; Female; Mammary Neoplas | 2019 |
Serum melatonin in dogs with congenital portosystemic shunting, with and without hepatic encephalopathy.
Topics: Animals; Case-Control Studies; Dog Diseases; Dogs; Female; Hepatic Encephalopathy; Male; Melatonin; | 2020 |
Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells.
Topics: Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Dog Diseases; Dogs; Female; Fluoresc | 2017 |
Evaluation of melatonin treatment in primary culture of canine mammary tumors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dog Diseases; Dogs; Dr | 2015 |
Color dilution alopecia in a blue Doberman pinscher crossbreed.
Topics: Administration, Oral; Alopecia; Animals; Antioxidants; Dog Diseases; Dogs; Hair; Hair Color; Male; M | 2009 |
THE THERAPEUTIC EFFECT OF MELATONIN ON CANINE MELANOSIS.
Topics: Animals; Dog Diseases; Dogs; Drug Therapy; Indoles; Melanocyte-Stimulating Hormones; Melanosis; Mela | 1965 |
The impact of body site, topical melatonin and brushing on hair regrowth after clipping normal Siberian Husky dogs.
Topics: Adjuvants, Immunologic; Administration, Topical; Alopecia; Animals; Dog Diseases; Dogs; Hair; Hair F | 2006 |
Oestrogen receptor evaluation in Pomeranian dogs with hair cycle arrest (alopecia X) on melatonin supplementation.
Topics: Alopecia; Animals; Dietary Supplements; Dog Diseases; Dogs; Female; Hair Follicle; Immunohistochemis | 2006 |
Acanthosis nigricans.
Topics: Acanthosis Nigricans; Animals; Dermatologic Agents; Diagnosis, Differential; Dog Diseases; Dogs; End | 1979 |